Abstract:In recent years, much interest has been generated over the potential of human embryonic stem cells in transplantation medicine. The groundbreaking study of Fraidenraich and colleagues conclusively demonstrated that rescue of lethal cardiac defects in Id knockout mutant mouse embryos was not due to transplanted embryonic stem cells giving rise to functional new tissues within the defective embryonic heart. Instead, there is indirect evidence that the observed therapeutic effect was due to various secreted factors emanating from the transplanted cells. This therefore introduces the exciting prospect of utilizing human embryonic stem cells as 'catalysts' to promote biological repair and regeneration in transplantation therapy. Nevertheless, the immunological barrier against allogenic transplantation, as well as the teratogenic potential of human embryonic stem cells poses major technical challenges. A possible strategy to overcome the immunological barrier may be to impose a temporary regimen of immunosuppressive drugs followed by their gradual withdrawal, once adequate tissue regeneration has been achieved. Other more novel alternatives include the use of microencapsulation to block interaction with the transplant recipient's immune system, and co-transplantation with bone marrow-derived mesenchymal stem cells, which have been demonstrated to possess immuno-suppressive properties. The teratogenic potential of human embryonic stem cells could possibly be alleviated by directing the differentiation of these cells to specific lineages prior to transplantation, or through mitotic inactivation. Co-transplantation with autologous adult stem cells may represent a novel strategy to further enhance the 'catalytic' effects of human embryonic stem cells. The various factors secreted by human embryonic stem cells could then have a concentrated localized effect on relatively large numbers of co-transplanted autologous adult stem cells, which may in turn lead to enhanced repair and regeneration of the damaged tissue or organ. This new therapeutic strategy needs to rigorously investigated, in view of its potentially important clinical applications.

On the Safety and Efficacy of Human Patient Stem Cell Transplantation Therapy

Stem Cells in Central Nervous System Diseases: Promising Therapeutic Strategies.

Stem Cells for the Treatment of Neurodegenerative Diseases

Human Amniotic Epithelial Stem Cells: A Promising Seed Cell for Clinical Applications

Significant Physical Improvement of Spinal Cord Injured Patients after Neural Stem Cell Transplantation

The Transplantation of Human Pluripotent Stem Cells is Safe: A Personal Experience During the Past 5 Years (I)

Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

New perspectives in human stem cell therapeutic research

Stem Cell Therapies in Clinical Trials: Progress and Challenges

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues

Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies

[Neural Stem Cells and Human Brain Regeneration Medicine].

Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.

Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus.

Advancements and challenges in stem cell transplantation for regenerative medicine

Engineered Stem Cells by Emerging Biomedical Stratagems

Embryonic Stem Cells: New Possible Therapy for Degenerative Diseases That Affect Elderly People.

The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives

Utilising Human Embryonic Stem Cells As ‘catalysts’ for Biological Repair and Regeneration. Challenges and Some Possible Strategies

Research progress in clinical trials of stem cell therapy for stroke and neurodegenerative diseases